To assess the potential cytotoxic effects of NOX1 inhibition in vitro, two human HCC cell lines (Huh7 and Hep3B) were treated for 24 hours with various concentrations of GKT771, ranging from 0 to 100 μM. The gene discussed is NOX1; the disease is hepatocellular carcinoma.